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Abstract 
 
Su(var)3-9, Enhancer-of-zeste, Trithorax (SET) domain–mediated lysine methylation, one of the 
major epigenetic marks, has been found to regulate chromatin-mediated gene transcription. 
Published studies have established, further, that methylation is not restricted to nuclear proteins 
but is involved in many cellular processes, including growth, differentiation, immune regulation, 
and cancer progression. The biological complexity of lysine methylation emerges from its 
capacity to cause gene activation or gene repression owing to the specific position of methylated-
lysine moieties on the chromatin. Accumulating evidence suggests that despite the absence of 
chromatin, viruses and prokaryotes also express SET domain–containing proteins, although their 
functional roles remain under investigated. One possibility is that SET domain–containing 
proteins in lower organisms have more than one biological function, for example in regulating 
lower organism growth or in manipulating host transcription machinery in order to establish 
infection. Involvement of SET domain–containing proteins in host–pathogen interactions would 
require a thorough understanding of their functions. This review discusses the role of 
methylation in both prokaryotes and lower eukaryotes, as well as the structural complexity and 
functional diversity within SET domain–containing proteins. 
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 Introduction 
 
Lysine methylation plays a central role in regulating growth, development, and immune response 
in normal conditions, however, its deregulation leads to pathological situations, including cancer, 
inflammation and developmental disorders [1-3]. Among the 20 ribosomal amino acids, lysine is 
perhaps the most versatile because it can facilitate the imprinting of diverse chemical 
modifications, such as acetylation, butyrylation, crotonylation, formylation, hydroxylation, 
malonylation, methylation, propionylation, ubiquitination, succinylation, and sumoylation [4-
10]. Lysine is enzymatically methylated by the addition of methyl group onto the N-amine group 
of its side chain.  Functionally, methylation of lysine residues (Kme) unfold at least two forms of 
complexities, namely, the position-specific methylation of a lysine residue and the degree of 
methylation, which includes monomethylation (Kme1), dimethylation (Kme2), and 
trimethylation (Kme3) [11, 12]. The biochemical outcome of methylation, therefore, provides 
plasticity to chromatin on gene promoters for orchestrating the process of gene regulation 
required for specific cellular processes. Besides the substrate, the catalytic activity of a lysine 
methyltransferase (KMT) is dependent upon the cofactor, S-adenosyl-L-methionine (SAM), 
which serves as a donor of methyl moieties [13, 14].  Although the functional significance was 
unclear, methylation of lysine was originally discovered in 1959 by Ambler and Rees in the 
flagellin protein of Salmonella typhimurium [15]. Subsequently, Murray, in 1964, demonstrated 
that methylation is prevalent on histone proteins [16].  Taken together, although a myriad of 
structural, functional, and biochemical studies have elucidated the key role of the SET domain in 
eukaryote proteins, a role in prokaryote proteins remains to be fully investigated. 
   
 The cellular panorama of lysine methylation casts dramatically opposite functional 
effects, ranging from silencing to activating target genes. For instance, in eukaryotes 
trimethylation of lysine 27 on histone H3 (H3K27me3) triggers transcriptional silencing, while 
trimethylation of lysine 4 on histone H3 (H3K4me3) is an epigenetic cue for transcriptional 
activation [17, 18].  Additionally, methylation of lysine 9 on histone H3 (H3K9me) signals 
transcriptional repression, which serves as a binding site for heterochromatin protein 1 (HP1) 
[19]. Further, H4K20 sites can undergo monomethylation (H4K20me1), dimethylation 
(H4K20me2), or trimethylation (H4K20me3). Though H4K20me1 has been linked to both gene 
activation and repression [20],   H4K20me2 and H4K20me3 are involved in cellular responses to 
DNA damage and cancer progression.  During a cellular response, H4K20me2 serves as a 
binding site for the tandem Tudor domains of 53BP1, which results in a 53BP1–H4K20me2 
complex [21]. On the other hand, a genome-wide investigation revealed that loss of H4K16ac 
and H4K20me3 is a hallmark for cancer progression [22]; for instance, loss of H4K20me3 
marks, which leads to hypomethylation of DNA repetitive sequences in the human genome, is a 
salient characteristic of cancer cells [22]. Collectively, histone methylation in higher eukaryotes 
is associated with pivotal cellular functions that if deregulated have the potential to cause a wide-
range of diseases.   
 
The biological significance of lysine methylation stems from its ability to alter the 
nuclear environment and nucleosomal architecture.  During X chromosome inactivation (Xi), the 
transient enrichment of enhancer of zeste homolog 2 (EED–EZH2) and H3K27me3 are 
characteristic of both embryonic and extraembryonic cells [23]. Subsequently, H3K27me3 
triggers chromatin condensation, which represses Xi-related gene expression. During 
 maintenance of X chromosome silencing, the inactive X chromosome undergoes further 
modification in which facultative heterochromatin is formed, allowing stabilization of gene 
repression that is independent of Xist expression in somatic cells [24-26].  In a different 
chromatin scenario, EZH2, together with the polycomb repressor complex, imprints H3K27me3 
marks on the promoters of Hox genes to regulate embryonic development. Hox antisense 
intergenic non-coding RNA (ncRNA) binds PRC2, which imprints H3K27me3 and thereby 
triggers silencing of Hox loci [27]. In addition to gene silencing, deregulated expression of EZH2 
correlates with the aggressiveness of breast and prostate cancer progression [28, 29], as EZH2 is 
expressed in human mammary epithelial cell lines stimulates anchorage-independent growth and 
cell invasion that, together, contribute to metastasis of tumor cells. There have been suggestions 
that overexpression of components of the PRC2 complex could disturb the stoichiometry, 
resulting in non-functional EZH2 and then uncontrolled proliferation of cancer cells [28, 29].   
Prokaryotes, which do not express histone proteins, have genes that encode SET domain–
containing proteins. Studies have shown that lysine amino acid of histone-like proteins in 
Chlamydia can be methylated [30]. Methylation also occurs in the pilin of Synechocystis sp., 
which regulates the motility of the cell. Recently, there has been suggestions and evidence that 
lysine methylation is involved in optimizing bacterial adherence to their environment [31].  Like 
bacteria and other prokaryotes, archaea lacks a nuclear membrane and histone modifying 
proteins, so the presence of SET protein is puzzling.  
Because there is very limited information on archaea in vivo, we perfoemed an 
evolutionary alignment to identify the archaeal homolog of eukaryotic histone modifying 
proteins (Fig. 1). The search was limited to archaeal homolog eukaryotic lysine 
methyltransferase because earlier studies provided evidence that KMT catalyzes methylation. In 
 Methanosarcina mazei a gene encoding a SET domain–containing protein was identified, 
confirming Aravind and Iyer's work [32]. Importantly, Methanosarcina mazei and its related 
species are obligate anaerobes, and are the only organisms capable of fermentation of acetate, 
methylamines, and methanol to methane, carbon dioxide, and ammonia [33]. The sequence 
alignment in Figure 1 highlights the conservation profile of the SET domain residues in the 
NHxxxPN motif across lower organisms and archaeal eukaryotes, while the phylogenetic tree 
emphasises the evolution of the complex post-SET domain containing the Zn2+ binding motif 
(CxCxxxxC) from the simpler non-Zn2+ binding organisms (Figure 2).   
 
Molecular and biochemical effects of methylation  
 
Chemical effects of methylation seem limited when compared to other posttranslational 
modifications such as acetylation, ubiquitination, and phosphorylation. Acetylation neutralizes 
the positive charge of lysine, as carbonyl dipole is added to enable interactions with 
bromodomain-containing proteins and deacetylases. On the other hand, phosphorylation rapidly 
alters the charge of proteins, while increasing the mass of the amino acid side chain, which can 
be detected using anti-phospho antibodies. In addition, ubiquitin and ubiquitin-like molecules 
increase the size of proteins––many involved in cell trafficking, transcriptional regulation, and 
endocytosis––and eventually leads to degradation. Methylation, taking part of relatively fewer 
modifications compared with other PTM's, can lead to relative increases in the mass of a protein, 
which can be established by mass spectrometry and anti-methylated antibodies; however, 
development of site- and position-specific mono-, di-, and tri-methylated antibodies is 
challenging.  Pulse-chase experiment provided evidence that methylation regulates 
ubiquitination. Further, deregulation of lysine methylation can result in significant effects and 
 lead to serious diseases, including cancers [56-58]. Upregulation of SMYD2, for example, is 
associated with esophageal squamous cell carcinoma and bladder cancer [59, 60].  
 
Viral SET protein methylates host chromatin on H3K27 to promote its replication 
Viruses engage with transcriptional machinery as well as recruit chromatin-associated proteins to 
maintain its genome and replication inside the host’s cells [34, 35]. However, Paramecium 
bursaria chlorella virus (PBCV-1) is an exception that encodes a SET domain–containing 
protein, namely, vSET, which methylates host (Chlorella) chromatin to silence the 
transcriptional machinery for enhancing its own replication [11].   
Specifically, the transcript of PBCV-1 is detected 5–10 minutes after infection of 
Chlorella cells, which indicates that transition from host to virus transcription is rapid. 
Interestingly, histone H3 protein from Chlorella NC64A demonstrates a high level of sequence 
homology with human histone H3 protein. This was substantiated by an in vitro methylation 
assay, which confirmed that vSET predominantly catalyzes dimethylation, with mild levels of 
monomethylation and trimethylation of H3K27 sites. Immunofluoresence investigations 
confirmed that vSET is present in the nucleus of the Chlorella after infection and co-localizes 
with H3K27me2. The methylation target of vSET is identical to the mammalian H3K27 
methyltransferase, EZH2; use of EZH2 knockdown in cells revealed that vSET could mimic the 
enzymatic action of EZH2 (Fig. 3). Importantly, H3K27me2 generated by vSET serves as a 
docking site for methyl-lysine binding protein CBX8, a component of PRC1 complex. Taken 
together, this was one of the first evidence clearly showing that a viral methyltransferase could 
provide a similar function as a mammalian protein. In addition, a recent study showed that 
 human cytomegalovirus targets the methyltransferase function of EZH2 to repress the 
transcriptional activity of GF1 [36]. 
 
BaSET regulates growth of Bacillus as well as host’s inflammatory response 
Human pathogens encode an extensive array of effector proteins that interact with chromatin-
mediated transcription process to overcome the resistance of host’s immune system [37].  
Numerous studies established that toxin secreted by Bacillus anthracis devastates host’s defense 
system [38, 39]. However, given severity of anthrax disease, it is highly likely that the profound 
immunosuppression after B. anthracis infection could be facilitated by additional factors.  It is 
also surprising that an independent SET protein that methylates chromatin within eukaryotes, is 
encoded by the B. anthracis (BaSET) (Fig. 3), which lacks histone proteins encapsulating its 
genome [32]. Moreover, investigations using bioinformatic tools argue that SET proteins in 
prokaryotes are mainly of evolutionary significance (Fig. 1). 
Data from a recently published study suggest that BaSET, unlike other SET proteins 
specifically trimethylates human histone H1 rather than histone proteins H3 and H4 [19]. To 
suppress host’s immune response most pathogens target the NF-κB-mediated signal pathway, 
hence, there was a strong possibility that B. anthracis utilizes BaSET to repress NF-κB 
transcriptional functions [12].  Experiments after infecting RAW cells, which is a macrophage 
derived murine cell line, demonstrated that BaSET secreted by B. anthracis is later translocated 
to the nuclei of macrophages to methylate histone H1, which repress transcription of 
inflammatory genes [12]. For pinpointing the specific effects of BaSET on the growth curve of 
B. anthracis revealed that BaSET could regulate the septation as well as delay the growth in a 
SET domain protein deletion mutant of B. anthracis BaΔSET.  On the other hand, as BaSET is 
 not required for spore formation and germination of heat-resistant endospore, mice infected with 
BaSET showed signs of symptoms and died within 4 days while mice infected with mutant 
BaSET survived.  This shows that BaSET plays a major role in the virulence of B. anthracis 
[12]. 
Usually, histone H3 and H4 are the most common target for methylation by eukaryotic 
SET proteins, which would normally result in gene activation or repression. However, it was 
discovered that BaSET methylates histone H1 and mass spectroscopy data suggest that possibly 
lysine 8 residues could be undergoing methylation.  Notably, eukaryotic methyltransferase, like 
EZH2 methylates more than one lysine residue.  Methylation at this site could be an early 
strategy by the bacillus to hypermethylate host chromatin to silence inflammatory response 
completely, which will be further devastated by the toxin secretion. Moreover, it is also indicated 
that histone H1 methylation by BaSET leads to transcription repression of inflammatory genes 
because of substrate selectivity of BaSET which will help establish B. anthracis in the host 
during the early stages of infection [12].     
 
cpnSET methylates histone like proteins for morphological switch 
Chlamydophila pneumoniae (Chlamydia pneumoniae) is an obligate intracellular eubacteria, 
which causes acute respiratory sickness that might involve chronic inflammatory processes, such 
as atherosclerosis and Alzheimer’s disease [40]. However, the underlying molecular mechanism 
after Chlamydophila infection, which leads to progression of chronic disease, remains unclear. 
Moreover, Chlamydiae exhibit a life cycle that switches between elementary bodies (EBs) and 
reticulate bodies (RBs). EBs represent transcriptionally inactive while RBs are transcriptionally 
active bodies [40]. After RBs developmental cycle, it is converted to EBs, which are infectious.  
 In Chlamydiae, there are two eukaryotic histone H1-like proteins, Hc1 and Hc2, which are 
mostly present in EBs.  Hc1 and Hc2 may be important for the morphological switching between 
RBs and EBs states. These histone-like proteins are probably regulated by SET gene whose 
proteins are similar to eukaryotic SET domain.  In one of the studies, Chlamydia SET protein has 
been shown to interact with Hc1 and Hc2 [41]. 
A Chlamydia SET domain–containing protein is composed of two distinct domains: 
CDC39 and SET (Fig. 3). The CDC39 domain is well conserved only in Chlamydia SET 
domain–containing proteins. In the genomes of Chlamydiae, ftsk, yycl and SET domain–
containing protein genes are closely located (in that order), which could suggest that they 
constitute a functional operon. A series of deletion mutants of cpn-SET (C. pneumoniae SET) 
reveal that Hc1 and Hc2 bind to substrate-binding region, which is essential for 
methyltransferase activity. Further, SET protein localization, and its interactions with Hc1 and 
Hc2 suggest that cpnSET methylates Hc1 and Hc2 proteins. Together, these results indicate that 
cpnSET directed methylation of Hc1 protein induces transformation of RBs to EBs state. 
Furthermore, cpnSET also methylates both murine histone H3 in vitro, however, cpnSET was 
localized mainly in Chlamydia cells, so it is possible that either Chlamydia SET protein are 
exported into the host cell or host histone proteins are transported into Chlamydia cells. 
 
The nuclear effector protein of Chlamydia trachomatis methylates chromatin 
Chlamydia trachomatis is a pathogenic bacterium that infects an estimated 92 million people 
annually and can be transmitted sexually, which also leads to blindness [30]. As pathogenic 
gram-negative bacteria, C. trachomatis encodes a type III secretion system (TTS) that allows the 
translocation of protein across a eukaryotic host membrane. Upon biochemical characterization, 
 Chlamydia SET domain–containing protein CT737, together with similar proteins in other 
Chlamydia species, were designated as nuclear effector (NUE) proteins [30]. 
NUE proteins sequenced from six Chlamydia species, including human pathogens 
Chlamydia trachomatis and C. pneumonia, are highly conserved homologs of CT737, which is 
consistent with the conclusion that NUE proteins play an important role in Chlamydia spp.  After 
transfection, NUE localizes in the nucleus of mammalian cells, like murine and human cells with 
the help of a nuclear localization signal.  NUE contains type III secretion (TTS) signal, which 
directs NUE to enter the nucleus. In the nucleus, results show that NUE is associated with 
chromatin in infected cells where it methylates H2B, H3, and, to a lesser extent, H4, but it does 
not methylate Chlamydia histone like protein Hc1 [30]. When exposed at equal concentration, 
mammalian histone prefers NUE compared to Chlamydia Hc1. In addition, NUE exhibits 
automethylation activity [57]. This automethylation primarily occurs within the NUE sequence, 
which regulates NUE activity towards histone. 
Human lysine methyltransferase G9a and EZH2 methylate different sites on histone 
proteins (Fig. 3). Chlamydia Hc1 and Hc2 proteins play a role in compacting DNA during 
transitions from RB to EB states. Hc1 acts as a substrate of C. pneumoniae NUE homolog in 
addition to histone H3; however, there were no Hc1 methylation in vitro studies. NUE is a 
methyltransferase as well as automethyltransferase, like G9a, which methylates its K239 site. 
 
Methylation of chromatin proteins by archaeal methyltransferase (aKMT) 
Archaea draw resemblance to Eukarya as it contains DNA-binding proteins, but exhibits 
structural and sequence differences (Fig. 3). Some of these differences can be attributed to 
archaea histone proteins, which lack N- and C- terminal tail, which are the primary sites for 
 modifications; however, all archaeal chromatin proteins other than histone proteins undergo 
some form of post-translational modifications [41, 42]. For instance, N- or C- terminal of 
architectural proteins Sul7d and Cren7 of Sulfolobus are monomethylated that affect gene 
expression and even thermal adaptation [43]. These methylation activities suggest that Archaea 
encodes lysine methyltransferase (KMT), which is similar to eukaryotic KMT4/DOT1 family. 
Accumulating evidences show that several DOT1- like proteins are present in Crearchaea and 
some euryarchaea despite low sequence identity with eukaryotic DOT1 proteins [60]. This 
DOT1 like protein, termed as aKMT, is quite similar to DOT1 protein of Saccharomyces 
cerevisiae. Nevertheless, aKMT lacks substrate recognition domain and contains a typical DOT1 
family methyltransferase catalytic core. Under varied circumstances, aKMT possesses intrinsic 
methyltransferase activity and interaction between the aKMT and substrates resulted in a hit and 
run model that is similar to the other eukaryotic DOT1, proposing that aKMT has the same 
essential function as eukaryotic DOT1 family [43, 44]. Further, evidence reveal that aKMT 
undergoes automethylation and this methylation can be inhibited by substrates such as Sul7d and 
Cren7, proteins that are methylated in archaea.  
On the other hand, there is little difference between methylated and unmethylated Sul7d 
and Cren7 in their ability to interact with DNA. However, lysine methylation on Sul7d has been 
thought to be very extensive as compared to Cren7, but a recent study suggests otherwise [45]. 
Cren7 is methylated at five lysine residues (K5, K11, K16, K31, and K42). Results show that 
aKMT4 in vitro methylates K11, K16, K36 but not K5 and K42 [46]. Lack of methylation 
activity on these lysine residues might be because of methylation efficiencies under various 
experimental conditions. aKMT plays a crucial role in post-translational modification of Cren7, 
but  it is not specific to Cren7. Mutation of Cren7 into various forms showed reduction in 
 methylation activity but not a complete halt of methylation. Methylation was halted only in the 
absence of any form of Cren7.  
 
ASHR3 SET methylates H3K36 in Arabidopsis to modulate cellular proliferation 
In Arabidopsis thaliana, the E2F–retinoblastoma (Rb) pathway controls DNA replication. 
Arabidopsis encodes three E2Fs (E2Fa, E2Fb, E2Fc) that can associate with a dimerization 
partner to gain activity. In association with Dpa, E2Fa causes cell proliferation and increases 
ploidy; E2Fb acts as an activator of cell proliferation; while E2Fc functions as a repressor [47-
49]. Overexpression of Rb-RELATED 1 (RBR1) protein, a transcriptional repressor, reduces 
E2F expression that causes loss of stem cell identity of root initials [50]. Moreover, the 
Arabidopsis gene ASH1 RELATED 3 (ASHR3) product has been identified as a SET domain–
containing protein that functions during the cell cycle (Fig. 3) and is regulated by E2Fa/E2Fb. 
Previous studies in Arabidopsis suggest that ATXR5 and ATXR6 encode an HKTMase, 
which monomethylates H3K27; but recent studies demonstrate that H3K36 sites can undergo 
mono and di -methylation also [51-54]. Mutation of ASHR3 reduces H3K36me1 and to some 
extent H3K36me2 [54]. However, to establish that ASHR3 can methylate two substrates lack 
convincing evidence. Apart from ASHR3, other proteins like ASHH and ASHR could potentially 
catalyze H3K36me [55]. These enzymes could act in other cellular or epigenetic context. Reports 
show that ASHR3 may be a target for E2Fa/E2Fb, while repressing or activating cell proliferation 
[54].  
 
Conclusions  
The phylogenetic analysis depicts the evolutionary history of the conserved SET domain/protein 
(Fig. 1). The branch lengths in the tree are proportional to the differences between the subfamily 
 clusters. The presence of the cysteine-rich post-SET domain sequence motif (CxCxxxxC) 
permits the coordination of Zn2+ ion, and is an evolutionary divergence from the simpler 
organisms. In spite of this evolution, the overall architectural fold of the S-adenosylmethionine/ 
S-adenosylhomocysteine cofactor-binding site and the post-SET motif–containing region, which 
coordinates Zn2+ ion is highly conserved (Figure 4). The subtle structural differences in the 
flanking regions around the catalytic site highlight the functional diversity and ability of these 
proteins to differentially recognize and methylate lysine-containing substrate in different histone 
and histone-like proteins (Figure 3). 
Emerging data have unraveled the biological role of methylation have come a long way 
in establishing this epigenetic phenomenon; however, further investigations are needed to 
understand the biological mechanisms that direct mutually exclusive modifications on a given 
lysine residue. Further, studies on methylation are looking outside of the nucleus to explain the 
consequences of methylation on non-histone and cellular proteins [61, 62]. Since prokaryotes 
lack histone proteins, understanding role of methylation on non-histone proteins will help to 
explain the role of SET domain–containing proteins in prokaryotes.  
In eukaryotic organisms, lysine acetylation is mainly associated with altering the 
chemical landscape of chromatin and gene activation; however, lysine methylation is a complex 
epigenetic event, as a site-specific methylation can either lead to gene activation or to repression 
[63]. Furthermore, like an acetylated-lysine moiety that mainly recruits bromodomain-containing 
proteins, a methylated-lysine moiety recruits a wide-range of proteins that contain chromo, 
Tudor, PHD, MBT, PWWP, and WDR domains [64]. Therefore, to depict molecular basis of 
physiological selectivity of histone methylation is relatively more challenging [64]. Moreover, 
methylation is carried out by a stoichiometry-dependent multi-protein complex, such as PRC2 
 complex that contains EZH2, which methylates H3K27 site [45]. After methylation, the 
H3K27me site recruits PRC1 complex that ultimately leads to gene silencing [28]. Given the 
multi-protein nature of the PRC1 and PRC2 complexes, in vitro purification is not simple. Any 
aberration in the H3K27 methylation can lead to neurological disorders, cancer, or inflammatory 
disorders [65]. In this kind of pathological situation, a SET domain–containing proteins from 
lower organisms, which do not function as a multi-protein complex, such as PBCV-1 vSET 
protein, can serve as a tool to restore methylation marks on H3K27 sites [66]. Furthermore, 
PBCV-1 vSET protein also has a potential to act as a therapeutic agent to institute repression 
marks on genes that are either hyperactivated or overexpressed in certain cancers. In addition, 
SET domain–containing proteins from prokaryotic organisms can serve as a mechanistic probe to 
investigate complex dynamics of gene activation or repression that occurs during eukaryotic 
gene regulation.  
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Figure legends 
 
Figure 1. A circular evolutionary tree of selected prokaryotic and unicellular eukaryotic versions 
of SET protein containing organisms. The evolution of complex post-SET domains (red), 
containing the Zn2+ binding motif (CxCxxxxC) is evident from non-Zn2+ binding organisms 
(blue). 
 
Figure 2. Multiple alignment of prokaryotic and unicellular eukaryotic SET domain containing 
proteins. The coloring represents the conservation profile of amino acid residues >70% (green) 
and >50% (yellow). The conserved SET domain residues in the NHxxxPN motif (red box) are 
labeled above the sequences. The post-SET domain consists of cysteine rich motif CxCxxxxC 
(blue box) and coordinates Zn2+ ion. 
 
Figure 3. A phylogenetic analysis and structural comparison of prokaryotic and unicellular 
eukaryotic SET proteins described in this review. While the signature SET domain NHxxxPN 
motif is conserved, there are subtle structural differences in the surrounding residues, which 
demonstrates their ability to methylate different histone and histone-like proteins. The presence 
of an additional post-SET domain (CxCxxxxC) in complex organisms binds Zn2+ ions, and is an 
evolutionary divergence from the simpler form. The conserved residues in the characteristic 
NHxxxPN motif, detailing the interactions in the catalytic site have been illustrated. The overall 
fold of the SET protein is illustrated as surface. The peptide (blue) containing the substrate lysine 
(red cpk) has been placed in the models to give a sense of position of binding. SAM/SAH are 
colored in green sticks. The models of the methylation sites have been illustrated for (A) 
Saccharomyces cerevisiae (B) Giardia lamblia (C) Plasmodium falciparum (D) Arabidopsis 
thaliana (E) Chalmydia trachomatis (F) Chlamydophila pneumoniae (G) Paramecium bursaria 
Chlorella Virus (H) Bacillus anthracis (I) Methanosarcina mazei. 
 
Figure 4. Alignment of the models, highlighting the structural conservation of the catalytic site 
containing the signature SET domain sequence NHxxxPN. The spatial position of the SAM/SAH 
cofactor is illustrated as green sticks and the presence of Zn2+ as white spheres.  
 
